Hexagon Bio raises US$77.3 million to advance discovery of medicinal molecules via microbial genomes [Full subscriber]

Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, announced on February 13 that it had raised US$77.3 million in Series B financing from venture investment.… Login to continue